Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

byCleveland ClinicNeoantigen screening design and genomic features of NSCLC cohort.a, WES was performed onn= 58 pre-therapy samples andn= 42 on-therapy samples, whi

Updated on: November 10,2024

Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

byCleveland ClinicNeoantigen screening design and genomic features of NSCLC cohort.a, WES was performed onn= 58 pre-therapy samples andn= 42 on-therapy samples, whi

Updated on:November 10,2024

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t

Updated on: April 20,2024

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t

Updated on:April 20,2024

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif

Updated on: February 20,2024

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif

Updated on:February 20,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan

Updated on: May 07,2024

Protein linked to aggressive skin cancer

by Lund UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Almost 300,000 people worldwide develop malignan

Updated on:May 07,2024

AI improving digestive cancer diagnosis, but data-sharing obstacles remain

by Health Data ScienceThe AI analysis workflow in digestive system neoplasms. SVM, support vector machine; LASSO, the least absolute shrinkage and selection operator; LN, lymph node; ROC, receiver ope

Updated on: January 02,2024

AI improving digestive cancer diagnosis, but data-sharing obstacles remain

by Health Data ScienceThe AI analysis workflow in digestive system neoplasms. SVM, support vector machine; LASSO, the least absolute shrinkage and selection operator; LN, lymph node; ROC, receiver ope

Updated on:January 02,2024

Some breast cancer patients with high responses to chemotherapy may not need surgery

by University of Texas M. D. Anderson Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit:

Updated on: February 20,2024

Some breast cancer patients with high responses to chemotherapy may not need surgery

by University of Texas M. D. Anderson Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit:

Updated on:February 20,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c

Updated on: March 12,2024

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c

Updated on:March 12,2024

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr

Updated on: May 25,2024

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr

Updated on:May 25,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024